Cellular uptake of a catechol iron chelator and chloroquine into Plasmodium falciparum infected erythrocytes

Biochemical Pharmacology

Volumn 65, Issue 8, 2003, Pages 1351-1360

  Hammadi, Akli ^a   Ramiandrasoa, Florence ^b   Sinou, Veronique ^c,d   Rogier, Christophe ^c,d   Fusai, Thierry ^c,d   Le Bras, Jacques ^e   Parzy, Daniel ^c,d   Kunesch, Gerhard ^b   Pradines, Bruno ^c,d  

^a DIF   (France)

^b UNIVERSITÉ PARIS SUD   (France)

^c Inst Méd Trop Serv S   (France)

^d Inst Fédératif R   (France)

^e BICHAT HOSPITAL   (France)

Author keywords

Accumulation; Chemotherapy; Iron chelators; Malaria; Siderophores

Indexed keywords

4 AMINOPYRIDINE; ADENOSINE TRIPHOSPHATASE (CALCIUM); AMILORIDE; ANTIMALARIAL AGENT; CALCIUM CHANNEL; CHLOROQUINE; CLOTRIMAZOLE; DIAZOXIDE; DILTIAZEM; FR 160; PICROTOXIN; POTASSIUM CHANNEL; SODIUM PROTON EXCHANGE PROTEIN; UNCLASSIFIED DRUG; VERAPAMIL;

ADJUVANT THERAPY; ARTICLE; CORRELATION ANALYSIS; DRUG ACCUMULATION; DRUG ACTIVITY; DRUG EXPOSURE; DRUG INHIBITION; DRUG MECHANISM; DRUG PENETRATION; DRUG UPTAKE; ERYTHROCYTE; IC 50; IRON METABOLISM; IRON TRANSPORT; NONHUMAN; PARASITOSIS; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; VERO CELL;

EID: 0037446373     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(03)00042-X     Document Type: Article

References (48)

1. Olliaro P., Wirth D. New targets for antimalarial drug discovery. J. Pharm. Pharmacol. 49:1997;29-33.
2. Hider R.C., Liu Z. The treatment of malaria with iron chelators. J. Pharm. Pharmacol. 49:1997;59-64.
3. Mabeza G.F., Loyevsky M., Gordeuk V.R., Weiss G. Iron chelation therapy for malaria: a review. Pharmacol. Ther. 81:1999;53-75.
4. Raventos-Suarez C., Pollack S., Nagel R.L. Plasmodium falciparum: inhibition of in vitro growth by desferrioxamine. Am. J. Trop. Med. Hyg. 31:1982;919-922.
5. Hershko C., Peto T.E.A. Desferoxamine inhibition of malaria is independent of host iron status. J. Exp. Med. 168:1988;375-387.
6. Fritsch G., Treumer J., Spira D.T., Jung A. Suppression of mouse infections by desferrioxamine B. Exp. Med. 60:1985;171-174.
7. Pollack S., Rosan R.N., Davidson D.E., Escajadillo A. Desferrioxamine suppresses Plasmodium falciparum in Aotus monkeys. Proc. Soc. Exp. Biol. Med. 184:1987;162-164.
8. Gordeuk V.R., Thuma P.E., Brittenham G.M., McLaren C., Parry D., Backentose A., Biemba G., Msiska R., Holmes L., McKinley E., Vargas L., Gilkeson R., Poltera A.A. Effect of iron chelation therapy on recovery from deep coma in children with cerebral malaria. New Engl. J. Med. 327:1992;1473-1477.
9. Mabeza G.F., Biemba G., Gordeuk V.R. Clinical studies of iron chelators in malaria. Acta Haematol. 95:1996;78-86.
10. Cabantchik Z.I. Iron chelators as antimalarials: the biochemical basis of selective cytotoxicity. Parasitol. Today. 11:1995;74-78.
11. Lytton S.D., Mester B., Libman J., Shanzer A., Cabantchik Z.I. Mode of action of iron(III) chelators as antimalarials. II. Evidence for differential on parasite iron-dependent nucleic acid synthesis. Blood. 84:1994;910-915.
12. Lytton S.D., Mester B., Dayan I., Glickstein H., Libman J., Shanzer A., Catbanchik Z.I. Mode of action of iron(III) chelators as antimalarials. I. Membranes permeation properties and cytotoxic activity. Blood. 81:1993;214-221.
13. Pradines B., Ramiandrasoa F., Basco L.K., Bricard L., Kunesch G., Le Bras J. In vitro activities of novel catecholate siderophore against Plasmodium falciparum. Antimicrob. Agents Chemother. 40:1996;2094-2098.
14. Pradines B., Rolain J.M., Ramiandrasoa F., Fusai T., Mosnier J., Rogier C., Daries W., Baret E., Kunesch G., Le Bras J., Parzy D. Iron chelators as antimalarial agents: in vitro activity of dicatecholate against Plasmodium falciparum. J. Antimicrob. Chemother. 50:2002;177-187.
15. Pradines B., Ramiandrasoa F., Rolain J.M., Rogier C., Mosnier J., Daries W., Fusai T., Kunesch G., Le Bras J., Parzy D. In vitro potentiation of antibiotic activities by a catecholate iron chelator against chloroquine-resistant Plasmodium falciparum. Antimicrob. Agents Chemother. 46:2002;225-228.
16. Vippagunta S.R., Dorn A., Bubendorf A., Ridley R.G., Vennerstrom J.L. Deferoxamine: stimulation of hematin polymerisation and antagonism of its inhibition by chloroquine. Biochem. Pharmacol. 58:1999;817-824.
17. Emerson L.R., Nau M.E., Martin R.K., Kyle D.E., Vahey M., Wirth D.F. Relationship between chloroquine toxicity and iron acquisition in Saccharomyces cerevisiae. Antimicrob. Agents Chemother. 46:2002;786-787.
18. Morgat J.L., Demares J., Cornu M. Dispositif automatique de transfert de gaz (tritium, deutérium, hydrogène). J. Labelled Compd. 11:1975;257-264.
19. Lambros C., Vanderberg J.P. Synchronization of Plasmodium falciparum erythrocytic stages in culture. J. Parasitol. 65:1979;418-420.
20. Bray P.G., Janneh O., Raynes K.J., Munghthin M., Ginsburgh H., Ward S.A. Cellular uptake of chloroquine is dependent on binding to ferriprotoporphyrin IX and is independent of NHE activity in Plasmodium falciparum. J. Cell Biol. 145:1999;363-376.
21. Pradines B., Alibert S., Houdoin C., Santelli-Rouvier C., Mosnier J., Fusai T., Rogier C., Barbe J., Parzy D. In vitro increase in chloroquine accumulation induced by dihydroethano-and ethenoanthracene derivatives in Plasmodium falciparum parasitized erythrocytes. Antimicrob. Agents Chemother. 46:2002;2061-2068.
22. Bray P.G., Boulter M.K., Ritchie G.Y., Howells R.E., Ward S.A. Relationship of global chloroquine transport and reversal of resistance in Plasmodium falciparum. Mol. Biochem. Parasitol. 63:1994;87-94.
23. Ye Z., van Dycke K. Reversal of chloroquine resistance in falciparummalaria by some calcium channel inhibitors and optical isomers is independent of calcium channel blockade. Drug Chem. Toxicol. 17:1994;149-162.
24. 2+ in Plasmodium falciparum-infected human blood cells. J. Physiol. 525:2000;125-134.
25. +-ATPase. J. Biol. Chem. 274:1999;33213-33219.
26. Wang Y., Takashi E., Xu M., Ayub A., Ashraf M. Downregulation of protein kinase C inhibits activation of mitochondrial K (ATP) channels by diazoxide. Circulation. 104:2001;85-90.
27. Nino A., Munoz-Caro C. Theoretical analysis of the molecular determinants responsible for the K(+) channel blocking by aminopyridines. Biophys. Chem. 91:2001;49-60.
28. Yoon K.W., Covey D.F., Rothman S.M. Multiple mechanisms of picrotoxin block of GABA-induced currents in rat hippocampal neurons. J. Physiol. 464:1993;423-439.
29. Berenbaum M.C. A method for testing for synergy with any number of agents. J. Infect. Dis. 137:1978;122-130.
30. Pouvelle B., Spiegel R., Hsiao L., Howard R.J., Morris R.L., Thomas A.P., Tarashchi T.F. Direct access to serum macromolecules by intraerythrocytic malaria parasites. Nature. 353:1991;73-75.
31. Loyevsky M., Lytton S.D., Mester B., Libman J., Shanzer A., Cabantchick Z.I. The antimalarial action of Desferal involves a direct access route to erythrocytic (Plasmodium falciparum) parasites. J. Clin. Invest. 91:1993;218-222.
32. 14C -Desferrioxamine B: uptake into erythrocytes infected with Plasmodium falciparum Z. Parasitikd. 72:1986;709-713.
33. Yayon A., Cabantchik Z.I., Ginsburg H. Susceptibility of human malaria parasites to chloroquine is pH dependent. Proc. Natl. Acad. Sci. U.S.A. 82:1985;2784-2787.
34. Krogstad D.J., Schlesinger P.H., Gluzman I.Y. Antimalarials increase vesicle pH in Plasmodium falciparum. J. Cell Biol. 101:1985;2302-2309.
35. Fitch C.D. Antimalarial schizonticides: ferriprotoporphyrin IX interaction hypothesis. Parasitol. Today. 2:1986;330-331.
36. Dorn A., Vippagunta S.R., Matile H., Jaquet C., Vennerstrom J.L., Ridley R.G. An assessment of drug-haematin binding as a mechanism for inhibition of haematin polymerisation by quinoline antimalarials. Biochem. Pharmacol. 55:1998;727-736.
37. Adovelande J., Deleze J., Schrevel J. Synergy between two calcium channel blockers, verapamil and fantofarone (SR33557), in reversing chloroquine resistance in Plasmodium falciparum. Biochem. Pharmacol. 55:1998;433-440.
38. Martiney J.A., Cerami A., Slater A.F.G. Verapamil reversal of chloroquine resistance in the malaria parasites Plasmodium falciparum is specific for resistant parasites and independent of weak base effect. J. Biol. Chem. 270:1995;22393-22398.
39. Carosi G., Caligaris S., Fadat G., Castelli F., Matteelli A., Komka-Bemba D., Roscigno G. Reversal of chloroquine resistance of wild isolates of Plasmodium falciparum by desipramine. Trans. R. Soc. Trop. Med. Hyg. 85:1991;723-724.
40. Pradines B., Alibert-Franco S., Houdoin C., Mosnier J., Santelli-Rouvier C., Papa V., Rogier C., Fusai T., Barbe J., Parzy D. In vitro reversal of chloroquine resistance in Plasmodium falciparum with dihydroethanoanthracene derivatives. Am. J. Trop. Med. Hyg. 66:2002;661-666.
41. Alibert S., Santelli-Rouvier C., Pradines B., Houdoin C., Parzy D., Karolak-Wojciechowska J., Barbe J. Synthesis and effects on chloroquine susceptibility in Plasmodium falciparum of a series of new dihydroanthracene derivatives. J. Med. Chem. 45:2002;3195-3209.
42. Kyle D.E., Milhous W.K., Rossan R.N. Reversal of Plasmodium falciparum resistance to chloroquine in Panamanian Aotus monkeys. Am. J. Trop. Med. Hyg. 48:1993;126-133.
43. Okonkwo C.A., Coker H.A.B., Agomo P.U., Ogunbanwo J.A., Mafe A.G., Agomo C.O., Afolabi B.M. Effect of chlorpheniramine on the pharmacokinetics of response to chloroquine of Nigerian children with falciparum malaria. Trans. R. Soc. Trop. Med. Hyg. 93:1999;306-311.
44. Sanchez C.P., Wünsch S., Lanzer M. Identification of a chloroquine importer in Plasmodium falciparum: differences in import kinetics are genetically linked with the chloroquine resistant phenotype. J. Biol. Chem. 272:1997;2652-2658.
45. Dzekunov S.M., Ursos L.M.B., Roepe P.D. Digestive vacuolar pH of intact intraerythrocytic P. falciparum either sensitive or resistant to chloroquine. Mol. Biochem. Parasitol. 110:2000;107-124.
46. Ursos L.M.B., Dzekunov S.M., Roepe P.D. The effects of chloroquine and verapamil on digestive vacuolar pH of P. falciparum either sensitive or resistant to chloroquine. Mol. Biochem. Parasitol. 110:2000;125-134.
47. Ursos L.M.B., Dubay K.F., Roepe P.D. Antimalarial drugs influence the pH dependent solubility of heme via apparent nucleation phenomena. Mol. Biochem. Parasitol. 112:2001;11-17.
48. Scott M.D., Ranz A., Kuypers F.A., Lubin B.H., Meshnick S.R. Parasite uptake of desferrioxamine: a prerequisite for antimalarial activity. Br. J. Haematol. 75:1990;598-603.